Primary acute myeloid leukemia cells with IDH1 or IDH2 mutations respond to a DOT1L inhibitor in vitro.

ABSTRACT:

SUBMITTER: Sarkaria SM 

PROVIDER: S-EPMC4262600 | biostudies-literature | 2014 Dec

REPOSITORIES: biostudies-literature